期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
结合传统性状客观化分析何首乌不同炮制方式与炮制程度的色彩色差 被引量:15
1
作者 张语凡 相乐康 +3 位作者 王鑫 袁金凤 彭诗涛 李飞 《中国实验方剂学杂志》 CAS CSCD 北大核心 2017年第20期1-7,共7页
目的:结合传统性状观察,对不同炮制方式下不同炮制程度的制何首乌进行色彩色差分析,为何首乌饮片颜色的客观数据化提供研究基础。方法:观察何首乌炮制品性状,采用CM-5型测色仪测定样品的L,a,b,计算色差值ΔE与总色值E,运用SAS 9.2统计... 目的:结合传统性状观察,对不同炮制方式下不同炮制程度的制何首乌进行色彩色差分析,为何首乌饮片颜色的客观数据化提供研究基础。方法:观察何首乌炮制品性状,采用CM-5型测色仪测定样品的L,a,b,计算色差值ΔE与总色值E,运用SAS 9.2统计软件进行聚类分析,分析炮制程度与色差检测结果的相关性。结果:2个产地的何首乌生品及其对照饮片粉末均为黄白色,E为70.31±3;制何首乌对照饮片粉末为棕褐色,E为52.24,与生何首乌对照饮片比较,ΔE为18.63;何首乌炮制后颜色加深,E降低,4种炮制方式显示相同的变化规律;且随炮制时间延长,颜色逐渐由棕黄色、浅棕色、深棕色、棕褐色直至变为棕黑色,其E也由61.11逐渐降至30.45,说明总色值能够表明何首乌的炮制程度。通过聚类分析可区分生品与炮制品,并将不同炮制程度的炮制品聚为一类。结论:色差仪的检测数据可以准确区分生何首乌与制何首乌,且能够客观准确地表达不同炮制程度的制何首乌粉末颜色变化。色彩色差检测可用于何首乌饮片的质量评价。 展开更多
关键词 何首乌 炮制 传统性状 色彩色差 制何首乌
原文传递
The status of Chinese medicine in reversing multi-drug resistance of hepatocellular carcinoma 被引量:3
2
作者 Shengli Yang Yunxia Wang Xiaoli Pan Zhifan Xiong 《The Chinese-German Journal of Clinical Oncology》 CAS 2011年第9期541-546,共6页
Multi-drug resistance(MDR) is a major obstacle in the chemotherapy of hepatocellular carcinoma.Comparing with western reversal agents,traditional Chinese medicine have advantages of low cost,hypotoxicity,wide safety r... Multi-drug resistance(MDR) is a major obstacle in the chemotherapy of hepatocellular carcinoma.Comparing with western reversal agents,traditional Chinese medicine have advantages of low cost,hypotoxicity,wide safety range,broad-spectrum and multi-targets,etc.Therefore,traditional Chinese medicine may be expected to open up a new path to reverse MDR of liver cancer.Studies about applying traditional Chinese medicine to reverse MDR in hepatocellular carcinoma are outlined below. 展开更多
关键词 Chinese medicine multi-drug resistance reversing hepatocellular carcinoma
下载PDF
郁金药材商品规格等级的历史沿革与现状分析 被引量:1
3
作者 陈洁 殷莉丽 +2 位作者 何金晓 敬勇 李敏 《中草药》 CAS CSCD 北大核心 2020年第23期6112-6118,共7页
郁金药材商品规格等级是评价郁金质量的重要指标,是实现药材"按质论价"的基础,对规范郁金市场交易以及保障郁金临床疗效有极其重要的作用。对郁金药材商品规格等级的历史沿革进行本草考证,并对其标准现状进行梳理,同时走访调... 郁金药材商品规格等级是评价郁金质量的重要指标,是实现药材"按质论价"的基础,对规范郁金市场交易以及保障郁金临床疗效有极其重要的作用。对郁金药材商品规格等级的历史沿革进行本草考证,并对其标准现状进行梳理,同时走访调查郁金市场现状以及产地现状。本草整理发现,传统上主要以产地指标与形状、颜色等性状指标来划分郁金规格等级及评价药材质量优劣;《76种药材商品规格标准》和《中药材商品规格等级(225种)》中主要以传统性状指标对郁金进行等级划分,分级指标单一;郁金目前处于市场自发分级状态,市场等级划分不统一;产地郁金均以统货销往各大药材市场和药厂,产地无分级。因此,基于本次规格等级考证与调查结果,提出完善与提升郁金药材商品规格等级标准,以促进药材优质优价交易体系的形成,同时为郁金药材商品规格等级国家标准或行业标准的制定提供参考。 展开更多
关键词 郁金 规格等级 历史沿革 市场分级 产地分级 传统性状
原文传递
Medicinal properties of Peganum harmala L. in traditional Iranian medicine and modern phytotherapy: a review 被引量:5
4
作者 Mina Cheraghi Niroumand Mohammad Hosein Farzaei Gholamreza Amin 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2015年第1期104-109,共6页
OBJECTIVE: To review the pharmacological activities of Peganum harmala L. (R harmala, Nitrariaceae) in traditional Iranian medicine (TIM) and mod- ern phytotherapy. METHODS: Opinions of TIM and modern phytothera... OBJECTIVE: To review the pharmacological activities of Peganum harmala L. (R harmala, Nitrariaceae) in traditional Iranian medicine (TIM) and mod- ern phytotherapy. METHODS: Opinions of TIM and modern phytotherapy about safety and acceptable dosage of this plant are discussed. Various medical properties of P. harmala were collected from important TIM references and added to scientific reports derived from modern medical databases like PubMed, Scirus, ScienceDirect and Scopus.RESULTS: The main medicinal part of the plant is the seed. In TIM resources, this plant possesses vari- ous Pharmacological activities such as carminative, galactagogue, diuretic, emmenagogue, antithrom-botic and analgesic. In modern phytotherapy, R harmala demonstrated numerous medicinal effects including cardiovascular, neurologic, antimicrobial, insecticidal, antineoplasmic, antiproliferative, gastrointestinal and antidiabetic effects. Adverse events such as neuro-sensorial symptoms, visual hallucination, bradycardia, hypotension, agitation, tremors, ataxia, abortion and vomiting cause peo- ple to use this plant cautiously. R harmala is contraindicated during pregnancy, due to its abortive and mutagenic activities. Because of increasing the expression of CYP1A2, 2C19, and 3A4 and inhi- bition of monoamine oxidase, the pharmacokinetic parameters of drugs which are mainly metabolized by these enzymes may be affected by R har- mala. CONCLUSION: The medicinal properties declared for this plant in TIM are compared with those showed in modern phytotherapy. Some of the TIM properties were confirmed in modern phytotherapy like emetic and analgesic activities and some have not been evaluated in modern phytotherapy such as its therapeutic effects on paralysis, epilepsy and numbness. Finally, the current review provides the evidence for other researchers to use TIM properties of P. harmala as an efficacious natural drug. Further preclinical and clinical studies for adequate evaluating safety and therapeutic efficacy are recommended. 展开更多
关键词 Peganum harmala Pharmacologicalphenomena Medicine traditional PHYTOTHERAPY REVIEW
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部